A carregar...
Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Multi-Site, Double-Blind, Randomized, Placebo-Controlled Trial
IMPORTANCE: Serotonin reuptake inhibitors (SRIs) are efficacious treatments for premenstrual dysphoric disorder (PMDD) when given either daily or for half the menstrual cycle during the luteal phase. Preliminary studies suggest SRI treatment can be shortened to the interval between symptom-onset and...
Na minha lista:
| Publicado no: | JAMA Psychiatry |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4811029/ https://ncbi.nlm.nih.gov/pubmed/26351969 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamapsychiatry.2015.1472 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|